Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Sparc Technologies (ASX: SPN) secures A$2.75M grant to advance hydrogen pilot plant commissioning Sparc Technologies secures A$2.75M grant to commission its Roseworthy green hydrogen pilot plant. Find out why investors are watching closely. byPallavi MadhirajuJuly 4, 2025